ResMed Inc. (RMD)

NYSE · Medical Instruments & Supplies

252.86
-0.20 (-0.08%)
Updated Oct 24, 5:08 AM ET
AI Rating
Strong Buy
Overall Score
84
Trend
84
Momentum
86
Risk
80

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 13, 2025 260 sessions Oct 23, 2026

AI Analysis

ResMed Inc. is trading at $252.86, down 0.08% on the session. The 50 day average sits at $226.98 and the 200 day at $225.03, which puts the stock in a uptrend. RSI is at 66.5, which reads as strong, and MACD is bullish crossover. Volume is volume spike.

The nearest support is around $218.66 with resistance near $242.40, so that band frames the current range. Average daily movement is roughly $5.36, or about 2.1% of the share price, which is what any stop placement has to allow for. The overall health score of 84 out of 100 combines a trend score of 84, momentum of 86 and a risk score of 80.

Technical indicators

RSI (14)
66.5
strong
MACD
3.643
bullish crossover
SMA 20
226.51
SMA 50
226.98
SMA 200
225.03
uptrend
ATR (14)
5.36
avg daily range
Support
218.66
Resistance
242.40
Volume vs 20d
2.24x
volume spike
Volatility
19.0%
annualised
1 month
+4.62%
3 months
+20.32%

AI trade signals on RMD

All signals
Date Setup Entry Target Stop R:R Status
Oct 20 Breakout ••.•• ••.•• ••.•• 2.95:1 Open
Aug 27 Breakout ••.•• ••.•• ••.•• 1.82:1 Stopped Out

About ResMed Inc.

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.